Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Andersen

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Internal Medicine|August 14, 2018
Genetics of metabolic traits in Greenlanders: lessons from an isolated populationM K Andersen, T Hansen
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Development of syndrome of inappropriate secretion of antidiuretic hormone during progression of metastatic breast cancerM K Andersen, J B Sørensen
Leukemia|January 19, 2000
Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromereM K Andersen, J Pedersen-Bjergaard
Journal of Internal Medicine|August 1, 1995
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant diseaseJ B Sørensen, M K Andersen, H H Hansen
Leukemia|September 13, 2003
Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemiaD H Christiansen, M K Andersen, J Pedersen-Bjergaard
Blood|May 29, 2000
Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantationJ Pedersen-Bjergaard, M K Andersen, D H Christiansen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosisD H Christiansen, M K Andersen, J Pedersen-Bjergaard
Leukemia|December 25, 2004
Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AMLM K Andersen, D H Christiansen, J Pedersen-Bjergaard
Diabetic Medicine : a Journal of the British Diabetic Association|November 20, 2012
Family history of Type 1 diabetes affects insulin secretion in patients with 'Type 2' diabetesV M Lundgren, M K Andersen, B Isomaa, et al.
Leukemia|October 26, 2002
Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalitiesJ Pedersen-Bjergaard, D H Christiansen, M K Andersen, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Internal Medicine|August 14, 2018
Genetics of metabolic traits in Greenlanders: lessons from an isolated populationM K Andersen, T Hansen
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Development of syndrome of inappropriate secretion of antidiuretic hormone during progression of metastatic breast cancerM K Andersen, J B Sørensen
Leukemia|January 19, 2000
Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromereM K Andersen, J Pedersen-Bjergaard
Journal of Internal Medicine|August 1, 1995
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant diseaseJ B Sørensen, M K Andersen, H H Hansen
Leukemia|September 13, 2003
Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemiaD H Christiansen, M K Andersen, J Pedersen-Bjergaard
Blood|May 29, 2000
Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantationJ Pedersen-Bjergaard, M K Andersen, D H Christiansen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosisD H Christiansen, M K Andersen, J Pedersen-Bjergaard
Leukemia|December 25, 2004
Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AMLM K Andersen, D H Christiansen, J Pedersen-Bjergaard
Diabetic Medicine : a Journal of the British Diabetic Association|November 20, 2012
Family history of Type 1 diabetes affects insulin secretion in patients with 'Type 2' diabetesV M Lundgren, M K Andersen, B Isomaa, et al.
Leukemia|October 26, 2002
Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalitiesJ Pedersen-Bjergaard, D H Christiansen, M K Andersen, et al.
Pageof 4